In RCC, abnormal activation of the PI3K/AKT/mTOR signaling pathway is highly prevalent,31 with extracellular signaling molecules and transmembrane receptors playing a pivotal role in initiating the activation of this pathway. The gene discussed is NRP1; the disease is renal cell carcinoma.